Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
•
Denosumab
What is the recommended timing for starting denosumab after completing zoledronic acid?
How do you minimize risks such as rebound bone loss or hypocalcemia during the transition?
Answer from: at Academic Institution
6 months
Sign In
or
Register
to read more
32258
Related Questions
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
Is Evenity appropriate for a patient with severe osteoporosis (T-score -3.1) unresponsive to bisphosphonates and persistent primary hyperparathyroidism despite two surgeries?
How soon after a fracture would it be safe to start anti-resorptive therapy?
How would you manage a patient who has been on denosumab for 7 years and is now found to have progressive bony erosions of the external auditory canal, which the treating neurotologist suspects are secondary to denosumab?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
In a patient with a history of parathyroidectomy (due to primary hyperparathyroidism) with low T- scores and high risk of fractures, is there any contraindication to give teriparatide/Forteo if PTH is in normal range after surgery?
How would you manage a patient with discordant TBS adjusted T-score and traditional T-score?
Are SGLT2 inhibitors contraindicated in patients with osteoporosis and history of vertebral and hip fractures?
How do you counsel patients on the risks and benefits of strontium supplements for osteoporosis management?
How do you approach decision-making around initiation of osteoporosis therapy in patients with advanced dementia?